Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Counterpoint: Successes in the Pursuit of Precision Medicine: Biomarkers Take Credit.

Journal of the National Comprehensive Cancer Network : JNCCN - 1 Jul 2017

Kato Shumei, Subbiah Vivek, Kurzrock Razelle

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to B7-H1 Antigen
Share to Clinical Trials as Topic
Share to Fusion Proteins, bcr-abl

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Rearrangement

Share to Immunotherapy

Share to Precision Medicine

Share to Proto-Oncogene Proteins c-kit

Source

Open in PubMed Open full text

Identifiers

PMID: 28687573
DOI: 10.6004/jnccn.2017.0127
PMCID: PMC6317845

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Counterpoint: Successes in the Pursuit of Precision Medicine: Biomarkers Take Credit.PMID 28687573Read ↗

Milestones of Precision Medicine: An Innovative, Multidisciplinary OverviewSemantic proximity Read ↗

Biomarker Tests Need Closer Scrutiny, IOM ConcludesSemantic proximity Read ↗

The Paradox of Precision Medicine.Semantic proximity Read ↗

Pharmacogenomics: time to rethink its role in precision medicine.Semantic proximity Read ↗

Precision Medicine for COVID-19: Phenotype Anarchy or Promise Realized?Semantic proximity Read ↗

Precision medicine with MET exon 14: a partial success.Semantic proximity Read ↗

Precision medicine for cancer with next-generation functional diagnosticsSemantic proximity Read ↗

Precision medicine – Delivering the goods?Semantic proximity Read ↗

The value proposition of molecular medicine.Semantic proximity Read ↗

Societal challenges of precision medicine: Bringing order to chaosSemantic proximity Read ↗

Personalized medicine gets practical.Semantic proximity Read ↗

Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.